Hispanic population: forgotten hereditary breast and ovarian cancer high risk group?

作者: Adrian Vilalta

DOI: 10.15406/JIG.2015.02.00028

关键词:

摘要: Pathogenic variants in the BRCA1 and BRCA2 genes have been recognized as major contributors to breast ovarian cancer risk since mid-1990s. While prevalence of mutations general population is estimated at 1:400, Hispanic has not established. However, significantly earlier age onset higher triple-negative tumors compared non-Hispanic White women are consistent with a high BRCA1/2 population. Recent studies shown that handful highly recurrent responsible for most hereditary women. Two particular, 185delAG exon9-12 del, prevalent can be traced back Spanish Amerindian founder populations respectively.

参考文章(21)
Cynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, Luis A. Herrera, Josef Herzog, Danielle Castillo, Alejandro Mohar, Clementina Castro, Lenny N. Gallardo, Dolores Gallardo, Miguel Santibáñez, Kathleen R. Blazer, Jeffrey N. Weitzel, Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer. ,vol. 121, pp. 372- 378 ,(2015) , 10.1002/CNCR.29058
Edith Caroline Smith, An Overview of Hereditary Breast and Ovarian Cancer Syndrome Journal of Midwifery & Women's Health. ,vol. 57, pp. 577- 584 ,(2012) , 10.1111/J.1542-2011.2012.00199.X
Jeffrey N. Weitzel, Veronica I. Lagos, Josef S. Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S. Ho, Charité N. Ricker, Katrina J. Lowstuter, Kathleen R. Blazer, Gail Tomlinson, Tom Scholl, Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families Cancer Epidemiology, Biomarkers & Prevention. ,vol. 16, pp. 1615- 1620 ,(2007) , 10.1158/1055-9965.EPI-07-0198
Rohini Roy, Jarin Chun, Simon N. Powell, BRCA1 and BRCA2: different roles in a common pathway of genome protection Nature Reviews Cancer. ,vol. 12, pp. 68- 78 ,(2012) , 10.1038/NRC3181
Esther M. John, Alexander Miron, Gail Gong, Amanda I. Phipps, Anna Felberg, Frederick P. Li, Dee W. West, Alice S. Whittemore, Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA. ,vol. 298, pp. 2869- 2876 ,(2007) , 10.1001/JAMA.298.24.2869
Eugenia E Calle, Michael J Thun, Obesity and cancer. Oncogene. ,vol. 23, pp. 6365- 6378 ,(2004) , 10.1038/SJ.ONC.1207751
Michele K. Evans, Dan L. Longo, PALB2 mutations and breast-cancer risk. The New England Journal of Medicine. ,vol. 371, pp. 566- 568 ,(2014) , 10.1056/NEJME1405784
Kristen J. Vogel, Deann P. Atchley, Julie Erlichman, Kristine R. Broglio, Kaylene J. Ready, Vicente Valero, Christopher I. Amos, Gabriel N. Hortobagyi, Karen H. Lu, Banu Arun, BRCA1 and BRCA2 Genetic Testing in Hispanic Patients: Mutation Prevalence and Evaluation of the BRCAPRO Risk Assessment Model Journal of Clinical Oncology. ,vol. 25, pp. 4635- 4641 ,(2007) , 10.1200/JCO.2006.10.4703
Jung-Young Park, Fan Zhang, Paul R. Andreassen, PALB2: the hub of a network of tumor suppressors involved in DNA damage responses. Biochimica et Biophysica Acta. ,vol. 1846, pp. 263- 275 ,(2014) , 10.1016/J.BBCAN.2014.06.003
Eliot M Rosen, Saijun Fan, Richard G Pestell, Itzhak D Goldberg, None, BRCA1 gene in breast cancer. Journal of Cellular Physiology. ,vol. 196, pp. 19- 41 ,(2003) , 10.1002/JCP.10257